We are live on ! Find out more
ALXA

Alexza Pharmaceuticals Inc
ALXA

Delisted

ALXA was delisted on the 16th of June, 2016.

30 hedge funds and large institutions have $20.7M invested in Alexza Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

602% more call options, than puts

Call options by funds: $7.37M | Put options by funds: $1.05M

Holders
30
Holders Change
+30
Holders Change %
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
30
Increased
Reduced
Closed
Calls
$7.37M
Puts
$1.05M
Net Calls
+$6.32M
Net Calls Change
+$6.32M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ALXA Hedge Fund Activity: Q2 2013 in Review

30 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q2 2013, worth a combined $20.7M.

Buyers outnumbered sellers: 30 funds opened new ALXA positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.

  • 30 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $20.7M of Alexza Pharmaceuticals Inc stock for Q2 2013.
  • 30 funds opened new Alexza Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +30 holders.

Based on aggregated 13F filings for Q2 2013.